Medverkande i utredning : Mats Karlsson

earch error="format unsupported" />

Centanni, Maddalena, Nanou, Afroditi, Terstappen, Leon W. M. M., Punt, Kees J. A., Coumans, Frank A. W., Karlsson, Mats O. och Friberg, Lena E., Longitudinal Analysis of Manually and Automatically Classified Circulating Tumor Biomarkers and their Prediction of Survival in Metastatic Colorectal Cancer, Clinical Pharmacology and Therapeutics, 2026, 119 nr 2, s. 403–413, : John Wiley & Sons

Dorofte, Luiza, Davidsson, Sabina, Carlsson, Jessica, Karlsson, Mats och Lillsunde-Larsson, Gabriella, Histological and Molecular Evaluation of HPV in Primary Tumors and Lymph Node Metastases of Penile Cancer, Cancers, 2026, 18 nr 9, : MDPI

Fragoulakis, Vasileios, Swen, Jesse J., Koufaki, Margarita-Joanna, Blagec, Kathrin, Blagus, Tanja, Bohringer, Stefan, Cambon-Thomsen, Anne, Cecchin, Erika, Cheung, Ka-Chun, Deneer, Vera H. M., Dupui, Mathilde, Jönsson, Siv, Joefield-Roka, Candace, Just, Katja S., Karlsson, Mats O., Konta, Lidija, Koopmann, Rudolf, Kriek, Marjolein, Lehr, Thorsten, Manson, Lisanne E. N., Rial-Sebbag, Emmanuelle, Rollinson, Victoria, Roncato, Rossana, Samwald, Matthias, Schaeffeler, Elke, Skokou, Maria, Schwab, Matthias, Steinberger, Daniela, Stingl, Julia C., Tremmel, Roman, Turner, Richard M., Rhenen, Mandy H. Van, Wouden, Cathelijne H. Van Der, Davila-Fajardo, Cristina Lucia, Dolzan, Vita, Pirmohamed, Munir, Sunder-Plassmann, Gere, Toffoli, Giuseppe, Guchelaar, Henk-Jan, Patrinos, George P. och Mitropoulou, Christina, Multinational cost-utility analysis of panel-based pharmacogenetics-guided treatment of patients enrolled in the U-PGx PREPARE study, eClinicalMedicine, 2026, 91, : Elsevier

Karlsson, Mats O. och Brundavanam, Divya, Addressing Causality and Homogeneity Assumptions in Exposure-Response Analyses, Clinical Pharmacology and Therapeutics, 2026, 119 nr 3, s. 703–712, : John Wiley & Sons

Lin, Yu-Jou, Okibedi, Frances, Karlsson, Mats O. och Svensson, Elin M., An Interactive Pharmacokinetic-Pharmacodynamic Framework to Evaluate Bedaquiline Dose Modifications in Adults With Tuberculosis, CPT, 2026, 15 nr 5, : John Wiley & Sons

Liu, Han, Advancing anticancer dose selection and individualization, 2026, Acta Universitatis Upsaliensis, Uppsala

Mazariegos Herrera, Andres, Karlsson, Mats O., Svensson, Elin M. och Dorlo, Thomas P. C., Weight-band-based simplification of oral allometric miltefosine dosing in paediatric patients with visceral leishmaniasis, Journal of Antimicrobial Chemotherapy, 2026, 81 nr 2, : Oxford University Press

Sundell, Jesper, Wahlquist, Ylva, Kjellsson, Maria, Karlsson, Mats och Soltesz, Kristian, Learning covariate relations in disease progression models using symbolic neural networks, CPT: Pharmacometrics and Systems Pharmacology, 2026, 15 nr 3, s. 9, : American Society for Clinical Pharmacology and Therapeutics

Sundell, Jesper, Wahlquist, Ylva, Kjellsson, Maria C., Karlsson, Mats O. och Soltesz, Kristian, Learning Covariate Relations in Disease Progression Models Using Symbolic Neural Networks, CPT, 2026, 15 nr 3, : John Wiley & Sons

Arrington, Leticia, van Dijkman, Sven C, Plan, Elodie L. och Karlsson, Mats O., Item Response Modeling and Artificial Neural Network for Differentiation of Parkinson's Patients and Subjects Without Evidence of Dopaminergic Deficit, CPT, 2025, 14 nr 5, s. 881–890, : John Wiley & Sons

Arrington, Leticia, Pharmacometric Evaluation of Item Response Modeling to Inform Clinical Drug Development, 2025, Acta Universitatis Upsaliensis, Uppsala

Centanni, Maddalena, Nijhuis, Janine, Karlsson, Mats O. och Friberg, Lena E., Comparative Analysis of Traditional and Pharmacometric-Based Pharmacoeconomic Modeling in the Cost-Utility Evaluation of Sunitinib Therapy, PharmacoEconomics (Auckland), 2025, 43 nr 1, s. 31–43, : Springer

Dam, Merete, Centanni, Maddalena, Centanni, Daniel, Friberg, Lena E., Karlsson, Mats O., Lynggaard, Line S, Johannsdottir, Inga M, Lepik, Kristi, Vaitkeviciene, Goda E, Griskevicius, Laimonas, Pöyhönen, Tuuli, Pyörälä, Marja, Jónsson, Ólafur G, Quist-Paulsen, Petter, Schmiegelow, Kjeld, Christoforaki, Tania Panagiota, Overgaard, Ulrik, Hansen, Stefan N och Albertsen, Birgitte K, Early prediction of subsequent peg-asparaginase inactivation in acute lymphoblastic leukaemia patients-A NOPHO ALL2008 study, British Journal of Haematology, 2025, 207 nr 5, s. 1920–1929, : John Wiley & Sons

Dorofte, Luiza, Davidsson, Sabina, Carlsson, Jessica, Lillsunde-Larsson, Gabriella och Karlsson, Mats, New histological risk grading system for prediction of lymph node metastasis in patients with penile cancer, Virchows Archiv, 2025, 486 nr 4, s. 759–767, : Springer

Guchelaar, Henk-Jan, van der Wouden, Cathelijne H., Manson, Lisanne E. N., Abdullah-Koolmees, Heshu, Blagec, Kathrin, Blagus, Tanja, Bohringer, Stefan, Cecchin, Erika, Cheung, Ka-Chun, Deneer, Vera H. M., Jönsson, Siv, Joefield-Roka, Candace, Just, Katja S., Karlsson, Mats O., Konta, Lidija, Koopmann, Rudolf, Kriek, Marjolein, Lehr, Thorsten, Mitropoulou, Christina, Rollinson, Victoria, Roncato, Rossana, Samwald, Matthias, Schaeffeler, Elke, Skokou, Maria, Schwab, Matthias, Steinberger, Daniela, Stingl, Julia C., Tremmel, Roman, Turner, Richard M., van Rhenen, Mandy H., Davila-Fajardo, Cristina L., Dolzan, Vita, Patrinos, George P., Pirmohamed, Munir, Sunder-Plassmann, Gere, Toffoli, Giuseppe och Swen, Jesse J., Pharmacogenetic Implementation Studies-Lessons Learned From the PREPARE Study, Clinical Pharmacology and Therapeutics, 2025, 118 nr 4, s. 803–812, : John Wiley & Sons

Haem, Elham, Karlsson, Mats O. och Ueckert, Sebastian, Comparison of the power and type 1 error of total score models for drug effect detection in clinical trials, Journal of Pharmacokinetics and Pharmacodynamics, 2025, 52 nr 1, : Springer

Hamdan, Alzahra, Traschütz, Andreas, Beichert, Lukas, Chen, Xiaomei, Gagnon, Cynthia, van de Warrenburg, Bart P., Santorelli, Filippo M., Basak, Nazli, Coarelli, Giulia, Horvath, Rita, Klebe, Stephan, Schüle, Rebecca, Hooker, Andrew C., Synofzik, Matthis och Karlsson, Mats O., Integrated Modeling of Digital-Motor and Clinician-Reported Outcomes Using Item Response Theory : Towards Powerful Trials for Rare Neurological Diseases, CPT, 2025, 14 nr 11, s. 1857–1868, : John Wiley & Sons

Helenius, Gisela, Lillsunde-Larsson, Gabriella, Karlsson, Mats G., Kaliff, Malin och Bergengren, Lovisa, Cervical screening with self-sampling for postmenopausal women with molecular triage using extended genotyping and methylation, European Journal of Obstetrics, Gynecology, and Reproductive Biology, 2025, 305, s. 404–409, : Elsevier

Hendrickx, Niels, Mentré, France, Hamdan, Alzahra, Karlsson, Mats O., Hooker, Andrew C., Traschütz, Andreas, Gagnon, Cynthia, Schüle, Rebecca, Synofzik, Matthis och Comets, Emmanuelle, Comparing randomized trial designs to estimate treatment effect in rare diseases with longitudinal models : a simulation study showcased by Autosomal Recessive Cerebellar Ataxias using the SARA score, BMC Medical Research Methodology, 2025, 25 nr 1, : BioMed Central (BMC)

Ibrahim, Eman I. K., Mechanism-based pharmacometric models to improve the development and use of anticancer therapies, 2025, Acta Universitatis Upsaliensis, Uppsala

Ibrahim, Moustafa M. A., Uusitupa, Matti, Tuomilehto, Jaakko, Lindström, Jaana, Kjellsson, Maria C. och Karlsson, Mats O., Competing Risks Analysis of the Finnish Diabetes Prevention Study, CPT, 2025, 14 nr 9, s. 1459–1469, : John Wiley & Sons

Ibrahim, Moustafa M. A., Kjellsson, Maria C. och Karlsson, Mats O., Response to "Enhance Multistate Models With Clinically Meaningful Graphs", CPT, 2025, 14 nr 12, s. 1899–1899, : John Wiley & Sons

Isaksson, Jonatan, Karlsson, Mats och Dijkstra, Jelke, Quantifying the response of piled structures from displacements induced by pile installation in soft clay, Canadian Geotechnical Journal, 2025, 62, : Canadian Science Publishing

Janssen, Saskia, Vongjarudech, Thanakorn, Karlsson, Mats O., Upton, Caryn M., Garcia-Prats, Anthony J., Diacon, Andreas H., Wiesner, Lubbe, Sachs, Tina, van der Laan, Louvina E., Salazar-Austin, Nicole, Hesseling, Anneke C. och Svensson, Elin M., Bridging to Paediatric Dosing : Relative Bioavailability of Suspended Rifapentine and Isoniazid in an Open-Label Randomized Trial in Adults on Tuberculosis Preventive Therapy, Clinical Pharmacokinetics, 2025, 64 nr 12, s. 1885–1896, : Springer Nature

Karlsson, Mats O., In the Cradle of Pharmacometric Methodology : Introducing Population PKPD Modeling, Simultaneous Analysis, and the Effect-Compartment Model-Commentary on Sheiner et al., Clinical Pharmacology and Therapeutics, 2025, 117 nr 6, s. 1516–1532, : John Wiley & Sons